Skip to main content
PMC home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1971 Feb;47(544):89–100.

Presensitization and kidney transplant failures

P I Terasaki, M Kreisler, R M Mickey
PMCID: PMC2467154  PMID: 4929402

Abstract

Over 1000 kidney transplant patients were tested for cytotoxic antibodies before transplantation.

It was found that patients with preformed antibodies had a significantly poorer outcome than those without antibodies in terms of clinical ranks and survival. This effect was over and above the instances of hyperacute failures previously shown to be associated with preformed cytotoxins.

Among patients who received second transplants from cadaver donors, an extremely high failure-rate was observed in patients who had developed antibodies following the first graft, whereas if antibodies were not present, the failure-rate was comparable with that of first transplants done in patients without antibodies.

By analysis of survival curves using logarithmic plots, it is postulated that pre-immunization has its greatest effect in the early 3-6 month high risk period and magnifies incompatibilities which occur with unrelated cadaver donors.

Full text

PDF
93

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barnes B. A. Survival data of renal transplantations in patients. Transplantation. 1965 Nov;3(6):812–825. doi: 10.1097/00007890-196511000-00038. [DOI] [PubMed] [Google Scholar]
  2. Hirata A. A., Terasaki P. I. Cross-reactions between streptococcal M proteins and human transplantation antigens. Science. 1970 May 29;168(3935):1095–1096. doi: 10.1126/science.168.3935.1095. [DOI] [PubMed] [Google Scholar]
  3. KIRKPATRICK C. H., WILSON W. E., TALMAGE D. W. IMMUNOLOGIC STUDIES IN HUMAN ORGAN TRANSPLANTATION. I. OBSERVATION AND CHARACTERIZATION OF SUPPRESSED CUTANEOUS REACTIVITY IN UREMIA. J Exp Med. 1964 May 1;119:727–742. doi: 10.1084/jem.119.5.727. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Mickey M. R., Vredevoe D. L., Terasaki P. I. Serotyping for homotransplantation. XI. Group classification based on posterior probabilities. Transplantation. 1967 Jul;5(4 Suppl):1071–1078. doi: 10.1097/00007890-196707001-00042. [DOI] [PubMed] [Google Scholar]
  5. Mittal K. K., Mickey M. R., Singal D. P., Terasaki P. I. Serotyping for homotransplantation. 18. Refinement of microdroplet lymphocyte cytotoxicity test. Transplantation. 1968 Nov;6(8):913–927. doi: 10.1097/00007890-196811000-00006. [DOI] [PubMed] [Google Scholar]
  6. Ockner S. A., Guttmann R. D., Lindquist R. R. Renal transplantation in the inbred rat. XIV. Mechanism of the modified rejection produced by bone marrow cell pretreatment. Transplantation. 1970 Jan;9(1):39–48. [PubMed] [Google Scholar]
  7. Patel R., Terasaki P. I. Significance of the positive crossmatch test in kidney transplantation. N Engl J Med. 1969 Apr 3;280(14):735–739. doi: 10.1056/NEJM196904032801401. [DOI] [PubMed] [Google Scholar]
  8. RAPAPORT F. T., CHASE R. M., Jr HOMOGRAFT SENSITIVITY INDUCTION BY GROUP A STREPTOCOCCI. Science. 1964 Jul 24;145(3630):407–408. doi: 10.1126/science.145.3630.407. [DOI] [PubMed] [Google Scholar]
  9. SIMONSEN M. STRONG TRANSPLANTATION ANTIGENS IN MAN. Lancet. 1965 Feb 20;1(7382):415–418. doi: 10.1016/s0140-6736(65)90009-7. [DOI] [PubMed] [Google Scholar]
  10. Serra A., O'Mathuna D. A theoretical approach to the study of genetic parameters of histocompatibility in man. Ann Hum Genet. 1966 Nov;30(2):97–118. doi: 10.1111/j.1469-1809.1966.tb00011.x. [DOI] [PubMed] [Google Scholar]
  11. Starzl T. E., Groth C. G., Terasaki P. I., Putnam C. W., Brettschneider L., Marchioro T. L. Heterologous antilymphocyte glubulin, histoincompatiblity matching, and human renal homotransplantation. Surg Gynecol Obstet. 1968 May;126(5):1023–1035. [PMC free article] [PubMed] [Google Scholar]
  12. Starzl T. E., Lerner R. A., Dixon F. J., Groth C. G., Brettschneider L., Terasaki P. I. Shwartzman reaction after human renal homotransplantation. N Engl J Med. 1968 Mar 21;278(12):642–648. doi: 10.1056/NEJM196803212781202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Takasugi M., Klein E. A microassay for cell-mediated immunity. Transplantation. 1970 Mar;9(3):219–227. doi: 10.1097/00007890-197003000-00005. [DOI] [PubMed] [Google Scholar]
  14. Terasaki P. I., Mickey M. R., Yamazaki J. N., Vredevoe D. Maternal-fetal incompatibility. I. Incidence of HL-A antibodies and possible association with congenital anomalies. Transplantation. 1970 Jun;9(6):538–543. [PubMed] [Google Scholar]
  15. Terasaki P. I., Singal D. P. Human histocompatibility antigens of leukocytes. Annu Rev Med. 1969;20:175–188. doi: 10.1146/annurev.me.20.020169.001135. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES